Virtual Library

Start Your Search

  • WCLC 2015

    16th World Conference on Lung Cancer

    Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado

    Presentation Date(s):  
    • September 6 - 9, 2015
    • Total Presentations: 2499

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

Filter Results:

Show Only Available Presentations

  • +

    P1.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC

    • Type: Poster
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 87
    • Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P1.01-065 - Bevacizumab Combined with Chemotherapy in the Treatment of Advanced NSCLC Patients

      09:30 - 09:30  |  Author(s): H. Tao

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P1.04 - Poster Session/ Biology, Pathology, and Molecular Testing

    • Type: Poster
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 116
    • Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P1.04-094 - NT5E(CD73) Is a Target of miR-30a-5p and Plays a Critical Role in Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Author(s): Z. Liu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P3.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC

    • Type: Poster
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 91
    • Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P3.01-050 - A Interim Analysis of Randomized Phase III Trial of Nedaplatin or Cisplatin Combined with Docetaxel as First-Line Treatment for Advanced ASQC

      09:30 - 09:30  |  Author(s): S. Lu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P3.02 - Poster Session/ Treatment of Localized Disease – NSCLC

    • Type: Poster
    • Track: Treatment of Localized Disease - NSCLC
    • Presentations: 41
    • Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P3.02-008 - Clinical Characteristics of EML4-ALK Positive and Surgically Resected NSCLC Patients

      09:30 - 09:30  |  Author(s): H. Tao

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MINI 27 - Biology and Other Issues in SCLC

    • Type: Mini Oral
    • Track: Small Cell Lung Cancer
    • Presentations: 15
    • Moderators:P.A. Bunn, Jr
    • Coordinates: 9/09/2015, 16:45 - 18:15, 605+607
    • +

      MINI27.13 - Progastrin-Releasing Peptide (ProGRP) as a Biomarker for Clinical Response in Small-Cell Lung Carcinoma (SCLC)

      17:55 - 18:00  |  Author(s): T. Muley

      • Abstract

      Loading...

  • +

    ORAL 42 - Drug Resistance

    • Type: Oral Session
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 7
    • Moderators:R.C. Doebele
    • Coordinates: 9/09/2015, 18:30 - 20:00, Mile High Ballroom 4a-4f
    • +

      ORAL42.05 - SMARCA4/BRG1 Is a Biomarker for Predicting Efficacy of Cisplatin-Based Chemotherapy in Non-Small Cell Lung Cancer (NSCLC)

      19:13 - 19:24  |  Author(s): E.H. Bell

      • Abstract

      Loading...